| Trial Identifier: | D6340C00002 |
| Sponsor: | AstraZeneca |
| Collaborator: | Takeda Pharmaceutical Company Ltd |
| NCTID: | NCT04449484 |
| Start Date: | August 2020 |
| Primary Completion Date: | January 2022 |
| Study Completion Date: | January 2022 |
| Condition: | Neurological & Brain - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, MI | Farmington Hills, MI, US, 48334 |
| US, IL | Chicago, IL, US, 60612 |
| US, GA | Atlanta, GA, US, 30331 |
| US, CA | Long Beach, CA, US, 90806 |
| US, FL | Hallandale Beach, FL, US, 33009 |
| US, TX | Houston, TX, US, 77058 |
| US, WA | Kirkland, WA, US, 98034 |
| US, WA | Spokane, WA, US, 99202 |
| US, OR | Portland, OR, US, 97239 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company